Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval
Jan 7 (Reuters) - The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug ...
Read moreJan 7 (Reuters) - The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug ...
Read moreAssets managed by sovereign wealth funds fell nearly 8%Assets of public pension funds dropped almost 6%LONDON, ...
Read moreDec 25 (Reuters) - Bloomberg L.P. has no interest in acquiring either Dow Jones or the ...
Read moreDec 22 (Reuters) - Tesla Inc (TSLA.O) is offering $7,500 discounts on Model 3 and Model ...
Read moreTOKYO, Dec 22 (Reuters) - Japan's stock market is drawing renewed interest from overseas investors, as ...
Read moreNEW YORK, Dec 16 (Reuters) - Goldman Sachs Group Inc (GS.N) is planning to cut thousands ...
Read moreTesla ships first Semi to PepsiCo five years after unveiling itNo details on orders or capacity ...
Read moreClimate change has big impact on economy, inflation - AmamiyaAug survey showed strong demand for green ...
Read moreGilead Sciences' (GILD) first-in-class cancer drug and GILD stock are finally hitting their stride. X The ...
Read moreOnline images show hundreds of workers protestingSurveillance cameras and windows smashed by men with sticksWorkers complain ...
Read more© 2022 TheDailyStock.News